A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008549/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To assess a new drug, BAY94-8862 given orally at different doses, to evaluate whether it was
safe and can help the well being of patients with type 2 diabetes and diabetic nephropathy.
These treatment doses were compared to placebo.
提供机构：
Vivli
创建时间：
2022-10-11
